Loading...
Immunotherapy of hepatocellular carcinoma
Newer immunotherapy agents may break the barrier that tumors create to evade the attack from the immune system. Dendritic cell vaccination has shown encouraging clinical activity and a favorable safety profile in advanced tumor stages. However, optimal cell maturation status, choice of tumor antigen...
Saved in:
| Published in: | Hepat Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Future Medicine Ltd
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6095173/ https://ncbi.nlm.nih.gov/pubmed/30190978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep.14.16 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|